跳到主要內容

Cartesian Therapeutics, Inc.

RNAC
交易所
Nasdaq
產業
Pharmaceutical Preparations
SEC CIK
0001453687

近 90 天,Cartesian Therapeutics, Inc. 沒有內部人公開市場買賣的申報;2026 年第 3 季末有 99 家機構在 13F 申報持有,市值合計 $6,302 萬;沒有大師持有。

持有 RNAC 5% 以上的大股東

最新一份 Schedule 13D 或 13G 申報持有 Cartesian Therapeutics, Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。

持有 RNAC 5% 以上的大股東
持有人最新表單持股變化首次申報最新申報原文
Springer Timothy A13D/A36.90%股數 955.5 萬+0.10 個百分點原本 36.80%2021/5/2713 份2025/1/15SEC
Kalayoglu Murat13D/A19.90%股數 583.4 萬–2023/11/224 份2026/4/2SEC
Squarepoint Ops LLC13G8.30%股數 221.0 萬新申報2026/3/131 份2026/3/13SEC

持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。

13D 與 13G 申報

Cartesian Therapeutics, Inc. 的 45 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。

RNAC 的 Schedule 13D、13G 申報
申報時間(美東)申報人表單持股變化事件日原文
2026/11/615:44 ETBarclays PLC13G/A0.02%股數 7,233−5.97 個百分點原本 5.99%低於 5%2026/9/30SEC
2026/8/1318:34 ETBarclays PLC13G5.99%股數 176.0 萬新申報2026/6/30SEC
2026/7/2213:11 ETJPMorgan Chase & Co13G/A4.80%股數 148.6 萬−1.30 個百分點原本 6.10%低於 5%2026/6/30SEC
2026/5/611:06 ETFMR LLC等 2 位13G/A3.00%股數 80.0 萬−2.30 個百分點原本 5.30%低於 5%2026/3/31SEC
2026/4/217:37 ETKalayoglu Murat等 4 位13D/A19.90%股數 583.4 萬–2026/3/31SEC
2026/3/1315:55 ETSquarepoint Ops LLC等 6 位13G8.30%股數 221.0 萬新申報2026/3/9SEC
2026/2/513:20 ETFMR LLC等 2 位13G/A5.30%股數 136.7 萬−3.00 個百分點原本 8.30%2025/12/31SEC
2025/11/511:30 ETFMR LLC等 2 位13G/A8.30%股數 215.6 萬−1.10 個百分點原本 9.40%2025/9/30SEC
2025/4/2514:57 ETJPMorgan Chase & Co13G6.10%股數 167.6 萬新申報2025/3/31SEC
2025/2/1209:28 ETFMR LLC等 2 位13G/A9.40%股數 242.3 萬–2024/12/31SEC
2025/1/1516:25 ETSpringer Timothy A等 3 位13D/A36.90%股數 955.5 萬+0.10 個百分點原本 36.80%2025/1/13SEC
2024/12/2320:22 ETSpringer Timothy A等 3 位13D/A36.80%股數 953.4 萬–2024/12/19SEC
2024/11/18Springer Timothy A13D/A舊制–––SEC
2024/10/15Kalayoglu Murat13D/A舊制–––SEC
2024/10/4Springer Timothy A13D/A舊制–––SEC
2024/9/27Springer Timothy A13D/A舊制–––SEC
2024/8/12FMR LLC13G舊制–––SEC
2024/7/12Artal International S.C.A.13G/A舊制–––SEC
2024/7/5Springer Timothy A13D/A舊制–––SEC
2024/5/10FMR LLC13G/A舊制–––SEC
2024/4/12Springer Timothy A13D/A舊制–––SEC
2024/4/10Kalayoglu Murat13D/A舊制–––SEC
2024/4/10Singer Michael13D/A舊制–––SEC
2024/3/28Springer Timothy A13D/A舊制–––SEC
2024/3/11FMR LLC13G/A舊制–––SEC
2024/2/14Mangrove Partners13G/A舊制–––SEC
2024/2/9Artal International S.C.A.13G/A舊制–––SEC
2024/2/9FMR LLC13G舊制–新申報–SEC
2023/11/22Singer Michael13D舊制–新申報–SEC
2023/11/22Kalayoglu Murat13D舊制–新申報–SEC
2023/11/17Springer Timothy A13D/A舊制–––SEC
2023/9/25Springer Timothy A13D/A舊制–––SEC
2023/6/12Artal International S.C.A.13G舊制–新申報–SEC
2023/2/14Mangrove Partners13G/A舊制–––SEC
2022/7/27Mangrove Partners13G舊制–––SEC
2022/5/24Mangrove Partners13G舊制–新申報–SEC
2022/5/915:23 ETBlackRock Inc.13G舊制–––SEC
2022/2/14Biotechnology Value Fund L P13G/A舊制–––SEC
2022/2/219:11 ETBlackRock Inc.13G/A舊制–––SEC
2021/12/27Springer Timothy A13D/A舊制–––SEC
2021/12/15Springer Timothy A13D/A舊制–––SEC
2021/5/27Springer Timothy A13D/A舊制–––SEC
2021/2/16Mangrove Partners Master Fund, Ltd.13G/A舊制–––SEC
2021/2/12EcoR1 Capital, LLC13G/A舊制–––SEC
2021/2/215:13 ETBlackRock Inc.13G舊制–新申報–SEC

Form 144:內部人預計賣出

高階主管、董事與其他關係人預計賣出 Cartesian Therapeutics, Inc. 股票的 17 份通知,由新到舊。

RNAC 的 Form 144
申報時間(美東)賣方預計賣出股數市值預計賣出日券商原文
2026/6/916:15 ETMilos Miljkovic前關係人3.50 萬$23.3 萬2026/6/9Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/6/216:07 ETMilos Miljkovic前關係人3,924$2.52 萬2026/6/2Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/1/1316:04 ETChristopher M Jewell前關係人9,000$6.89 萬2026/1/13Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/1/916:35 ETChristopher M Jewell前關係人1,510$1.21 萬2026/1/9Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/11/1916:36 ETChristopher M Jewell前關係人2.69 萬$19.3 萬2025/11/19Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/12/1016:21 ETMetin Kurtoglu高階主管2,901$7.06 萬2024/12/10Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/12/916:36 ETMetin Kurtoglu高階主管1.08 萬$27.4 萬2024/12/9Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/2116:45 ETMetin Kurtoglu高階主管3.28 萬$54.7 萬2024/11/21Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/2016:57 ETMetin Kurtoglu高階主管5,700$9.86 萬2024/11/20Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1916:36 ETMetin Kurtoglu高階主管200$3,9002024/11/19Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1816:24 ETMetin Kurtoglu高階主管3.44 萬$63.3 萬2024/11/18Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1517:07 ETMetin Kurtoglu高階主管2.21 萬$37.9 萬2024/11/15Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1516:57 ETChristopher M Jewell高階主管1.61 萬$27.4 萬2024/11/15Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1516:44 ETMilos Miljkovic高階主管2.00 萬$34.3 萬2024/11/15Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1417:30 ETMetin Kurtoglu高階主管2.59 萬$42.6 萬2024/11/14Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1417:29 ETChristopher M Jewell高階主管3.60 萬$60.1 萬2024/11/14Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2024/11/1417:13 ETMilos Miljkovic高階主管3.50 萬$56.5 萬2024/11/14Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC